Life Tech Reports Growth for PGM in Q1, Ships Early-Access Ion Protons; Full Launch by End of Q3 | GenomeWeb

This article, originally published April 25, has been updated with information from analyst reports.

Life Technologies this week reported a 7 percent increase in first-quarter revenues for its Genetic Analysis group, driven mainly by higher sales of Ion Torrent and capillary electrophoresis products.

Genetic Analysis revenues totaled $356 million, a 4 percent increase after currency effects. The growth in Ion Torrent and CE products was offset by an expected decrease in qPCR royalty revenues and lower sales of SOLiD products.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.